Pectin-based systems for colon-specific drug delivery via oral route
Related Experiment Video
Updated: Sep 26, 2026

Validation of Therapeutic Agent Conjugation to Polyvinyl Alcohol-Coated Medical Devices
Published on: November 29, 2024
LinShu Liu1, Marshall L Fishman, Joseph Kost
1US Department of Agriculture, ARS, Eastern Regional Research Center, 600 East Mermaid, Lane, Wyndmoor, PA 19038, USA. lsliu@arserrc.gov
Abstract:
Pectin-derived matrices are now being examined and tested for controlled drug delivery. Pectin is intact in the upper gastrointestinal tract and degraded by colonic microflora. The composition of this microflora remains relatively consistent across a diverse human population. Thus, pectin-derived drug carriers provide promising potential for colon-specific drug delivery. This paper reviews recent developments in pectin-derived formulations. Subjects reviewed include gelation of pectin, calcium cross-linked pectinate, composites of pectin and other polymers, technologies to fabricate pectin into useful drug delivery vehicles, and methods to evaluate release kinetics of incorporated drugs. This article discusses advantages, limitations, and possible future developments in pectin-based formulations with particular emphasis on the field of colon-specific drug delivery.
Related Concept Videos
Oral Drug Delivery Systems: Delayed-Release Systems
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Oral Drug Delivery Systems: Continuous-Release Systems
Modified-Release Drug Delivery Systems: Site-Targeted
Oral Drug Delivery Systems: Introduction
Carrier-Mediated Transport
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...

